Literature DB >> 23524621

Association of the Period3 clock gene length polymorphism with salivary cortisol secretion among police officers.

Michael Wirth1, James Burch, John Violanti, Cecil Burchfiel, Desta Fekedulegn, Michael Andrew, Hongmei Zhang, Diane B Miller, Shawn D Youngstedt, James R Hébert, John E Vena.   

Abstract

OBJECTIVE: This study evaluated whether measures of waking or diurnal cortisol secretion, or self-reported psychological disturbances differed among police officers with a Period3 (PER3) clock gene length polymorphism.
METHODS: The cortisol awakening response was characterized via the area under the salivary cortisol curve with respect to the increase (AUCI) or total waking cortisol (AUCG). Diurnal cortisol measures included the slope of diurnal cortisol and the diurnal AUCG. Psychological disturbances were characterized using the Center for Epidemiologic Studies Depression Scale, Impact of Events Scale, and Life Events Scale.
RESULTS: Officers with a 4/5 or 5/5 genotype had higher awakening AUCG and greater diurnal cortisol AUCG levels compared to officers with the 4/4 genotype. Among those working more afternoon or night shifts, waking AUCI and AUCG were greater among officers with a 4/5 or 5/5 genotype compared to the 4/4 referents.
CONCLUSION: Cortisol secretion was modified among police officers with different PER3 VNTR clock gene variants.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23524621      PMCID: PMC3655703     

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  80 in total

1.  Circadian clock genes oscillate in human peripheral blood mononuclear cells.

Authors:  Diane B Boivin; Francine O James; Aibin Wu; Park F Cho-Park; Huabao Xiong; Zhong S Sun
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

Review 2.  Psychosocial factors, biological mediators, and cancer prognosis: a new look at an old story.

Authors:  Yori Gidron; Alain Ronson
Journal:  Curr Opin Oncol       Date:  2008-07       Impact factor: 3.645

3.  Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock.

Authors:  K Bae; X Jin; E S Maywood; M H Hastings; S M Reppert; D R Weaver
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

4.  PTSD symptoms predict waking salivary cortisol levels in police officers.

Authors:  Thomas C Neylan; Alain Brunet; Nnamdi Pole; Suzanne R Best; Thomas J Metzler; Rachel Yehuda; Charles R Marmar
Journal:  Psychoneuroendocrinology       Date:  2005-01-11       Impact factor: 4.905

5.  Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I.

Authors:  Lisa W Chu; Yong Zhu; Kai Yu; Tongzhang Zheng; Anand P Chokkalingam; Frank Z Stanczyk; Yu-Tang Gao; Ann W Hsing
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

6.  A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference.

Authors:  Simon N Archer; Donna L Robilliard; Debra J Skene; Marcel Smits; Adrian Williams; Josephine Arendt; Malcolm von Schantz
Journal:  Sleep       Date:  2003-06-15       Impact factor: 5.849

7.  Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.

Authors:  Yong Zhu; Richard G Stevens; Aaron E Hoffman; Liesel M Fitzgerald; Erika M Kwon; Elaine A Ostrander; Scott Davis; Tongzhang Zheng; Janet L Stanford
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

Review 8.  PERIOD3, circadian phenotypes, and sleep homeostasis.

Authors:  Derk-Jan Dijk; Simon N Archer
Journal:  Sleep Med Rev       Date:  2009-08-29       Impact factor: 11.609

9.  Shift work and health.

Authors:  Margot Shields
Journal:  Health Rep       Date:  2002-07       Impact factor: 4.796

Review 10.  Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes.

Authors:  Elizabeth A Yu; David R Weaver
Journal:  Aging (Albany NY)       Date:  2011-05       Impact factor: 5.682

View more
  5 in total

1.  Daytime Sleep Disturbance in Night Shift Work and the Role of PERIOD3.

Authors:  Philip Cheng; Gabriel Tallent; Helen J Burgess; Kieulinh Michelle Tran; Thomas Roth; Christopher L Drake
Journal:  J Clin Sleep Med       Date:  2018-03-15       Impact factor: 4.062

2.  Case-control study of breast cancer in India: Role of PERIOD3 clock gene length polymorphism and chronotype.

Authors:  Michael D Wirth; James B Burch; James R Hébert; Pradnya Kowtal; Aparna Mehrotra-Kapoor; Susan E Steck; Thomas G Hurley; Prakash C Gupta; Mangesh S Pednekar; Shawn D Youngstedt; Hongmei Zhang; Rajiv Sarin
Journal:  Cancer Invest       Date:  2014-06-06       Impact factor: 2.176

3.  Case-control study of the PERIOD3 clock gene length polymorphism and colorectal adenoma formation.

Authors:  Melannie Alexander; James B Burch; Susan E Steck; Chin-Fu Chen; Thomas G Hurley; Philip Cavicchia; Meredith Ray; Nitin Shivappa; Jaclyn Guess; Hongmei Zhang; Shawn D Youngstedt; Kim E Creek; Stephen Lloyd; Xiaoming Yang; James R Hébert
Journal:  Oncol Rep       Date:  2014-12-11       Impact factor: 3.906

4.  Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3VNTR polymorphisms and gene co-expression.

Authors:  Jaume Fores-Martos; Raimundo Cervera-Vidal; Julia Sierra-Roca; Carlos Lozano-Asencio; Vita Fedele; Sten Cornelissen; Hege Edvarsen; Irene Tadeo-Cervera; Pilar Eroles; Ana Lluch; Rafa Tabares-Seisdedos; Antonio Falcó; Laura J Van't Veer; Marjanka Schmidt; David A Quigley; Anne-Lise Børresen-Dale; Vessela N Kristensen; Allan Balmain; Joan Climent
Journal:  NPJ Breast Cancer       Date:  2021-09-10

5.  PER1 rs3027172 Genotype Interacts with Early Life Stress to Predict Problematic Alcohol Use, but Not Reward-Related Ventral Striatum Activity.

Authors:  David A A Baranger; Chloé Ifrah; Aric A Prather; Caitlin E Carey; Nadia S Corral-Frías; Emily Drabant Conley; Ahmad R Hariri; Ryan Bogdan
Journal:  Front Psychol       Date:  2016-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.